Health·Updated hourly·1,982 stories
Medical breakthroughs, public health and scientific discoveries — quick news summary
Salk Institute researchers discovered that supplementing mice with the dietary amino acid methionine dramatically improved survival during severe infections by enhancing kidney filtration and clearing
Revolution Medicines' second‑line pancreatic cancer drug daraxonrasib more than doubled median survival and cut death risk by 60% in a new study, prompting an FDA‑authorized early‑access rollout. At t
A one‑year course of the biologic drug abatacept can postpone the onset of rheumatoid arthritis by up to four years, even after treatment stops. The finding comes from a long‑term follow‑up of 213 hig
Families are demanding blood from unvaccinated donors, fearing vaccine residues, but hospitals say regulatory rules don’t label blood by donor vaccination status, leaving physicians caught between pat
Almost 50 more genes have been flagged as being linked to Alzheimer’s, along with changes in activity in crucial cells t...
A long-overlooked organ may hold surprising clues to healthy aging and cancer survival
Kenyan youths rallied in Nanyuki to block a U.S.-planned Ebola quarantine at Laikipia Air Base, a project the High Court has paused amid concerns over the country’s fragile health system and local exp
The arbitration process has protected patients but generated financial windfalls for some clinicians.
General Catalyst’s October acquisition of Summa Health is being used as a testbed for a rapid‑tech transformation led by Health Assurance Transformation Company. The plan rolls out AI‑driven phone cal
A new study of 120 bird species reveals that self‑pleasuring is a widespread, natural behavior in wild birds, challenging the view that it is a stress‑induced response to captivity and that interventi
A new daily pill, daraxonrasib, has been shown to nearly double survival for patients with advanced pancreatic cancer by targeting the KRAS mutation. In a 500‑patient trial across three continents, me
ASCO Day 3: A huge advance for pancreatic cancer, a let down for Akeso and Summit, and a new approach to immunotherapy.
Low-dose, low-cost immunotherapies may help patients in poorer countries access high-tech cancer treatments.
Scripps researchers identified that a chemical modification of the STING protein drives chronic brain inflammation in Alzheimer’s disease. Blocking this switch in mice reduced inflammation and protect
A new study from Fox Chase Cancer Center shows that melanoma metastasis is lowest in young mice, spikes in middle‑aged mice, and falls again in very old mice. The pattern links to a decline in protect
The U.S. military conducted a Saturday strike on an alleged drug‑smuggling boat in the eastern Pacific, killing three men and raising the campaign’s death toll to 205 in a month‑long operation.
A 500‑patient trial of the KRAS‑targeting pill daraxonrasib showed metastatic pancreatic cancer patients lived an average of 13.2 months—about twice as long as those on chemotherapy—while experiencing
A pivotal trial of Revolution Medicines’ KRAS‑G12C inhibitor daraxonrasib showed pancreatic cancer patients lived nearly twice as long as those on standard chemotherapy, a result hailed as practice‑ch
A Phase 3 PROTEUS trial showed that giving high‑risk prostate cancer patients two hormone drugs before and after prostatectomy outperforms the standard single‑drug regimen. The findings, hailed as a “
Australian biotech Cortical Labs has trained 200,000 lab-grown human brain cells on a silicon chip to play the 1990s shooter game Doom, demonstrating goal-directed learning in biological neurons and h
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.